Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06526039 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To assess outcome of treatment and safety among patients with rifampicin-resistant isoniazid-susceptible pulmonary tuberculosis treated with a novel regimen consisting of isoniazid, bedaquiline, and moxifloxacin throughout for 6 months, supplemented by pyrazinamide for the initial 2 months.
Trial Details
NCT Number NCT06526039
Lead Sponsor Taipei Medical University WanFang Hospital
Collaborators: Hualien Tzu Chi General Hospital, Chest Hospital, Ministry of Health and Welfare, Taiwan, Chang-Hua Hospital, Taichung Veterans General Hospital, Taichung Hospital, Ministry of Health and Welfare, Taoyuan General Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions
(from sponsor)		 Tuberculosis, Pulmonary
Related terms Tuberculosis, Tuberculosis, Pulmonary
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov